Magenta Therapeutics
Magenta researches, develops and commercializes hematopoietic stem cell transplants for the treatment of immune and blood-based diseases.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Magenta Therapeutics Information
Geographic Data
Address: 50 Hampshire Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$86M
Raised Total:$220M
Social
Metrics
2,494,237Website Global Rank
7,235Website Monthly Traffic
Twitter Followers
Description
Magenta researches, develops and commercializes hematopoietic stem cell transplants for the treatment of immune and blood-based diseases.
Contact Phone:
+18572420170
Contact Email:
Magenta Therapeutics went public on 6/20/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2018
IPO Valuation:
$515M
Ticker Symbol:
MGTA
IPO Price:
$15/share
Amount Raised:
$100M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
